CE Activities
PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases
December 12, 2023FEATURING: Garvin H. Davis, MD, Jeffrey Dunn, PharmD, MBA
PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm
October 3, 2023FEATURING: Ferhina S. Ali, MD, MPH, FASRS, Steven S. Kheloussi, PharmD, MBA, FAMCP
PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP)
October 2, 2023FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD
PayerTalkCE presents: Unmet Needs in AMD and DME
September 27, 2023FEATURING: Steven S. Kheloussi, PharmD, MBA, FAMCP, Jordan M. Graff, MD, FACS
Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Managed Care Pathway for Better Management of Retinal Vein Occlusion (RVO)
January 31, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA
Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations: Managed Care Pathway for Better Management of Age-related Macular Degeneration (AMD)
January 31, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA
Facilitating Optimal Outcomes for the Management of Retinal Diseases:Health Plan Best Practice RecommendationsManaged Care Pathway for Better Management of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
January 3, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA, Matt White, JD
Spotlight on Diabetic Retinopathy & Diabetic Macular Edema
November 1, 2022FEATURING: W. Lloyd Clark, MD, Jeffrey Dunn, PharmD, MBA, and Dana McCormick, RPh, FAMCP
Spotlight on Age-Related Macular Degeneration
November 1, 2022FEATURING: Ryan Bitton, PharmD, MBA, David M. Brown, MD, and Jeffrey Dunn, PharmD, MBA
Spotlight on Retinal Vein Occlusion
November 1, 2022FEATURING: David M. Brown, MD, Jeffrey D. Dunn, PharmD, MBA, and Jason Parrott, MBA